The FDA has recalled Baxter International’s Colleague infusion pumps after the company failed to take proper and timely corrective action to fix problems with the IV pumps. “Baxter has failed to adequately correct, within a reasonable timeframe, the deficiencies in the Colleague infusion pumps still in use,” the FDA wrote in a letter it sent Baxter on Tuesday.
The IV pump recall affects approximately 200,000 pumps that are primarily used in hospital settings. The pump defects can be serious because they may shut down or failed to deliver the correct amount of medication to the patient.
Electronic infusion pumps in general have come under FDA scrutiny recently as the federal agency has received an increase in the number of adverse events involving the IV pumps.
- New Hampshire Doctor Who Plead Guilty to Sexually Assaulting a Patient Sentenced 5-10 Years - September 10, 2019
- Unsolicited Patient Observations Help Identify Surgeons More Likely to Commit Malpractice - August 1, 2018
- Lead Extractions in Catherization Labs May Result in Wrongful Death - February 19, 2018